Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine/Lobaplatin vs Gemcitabine/Cisplatin in Metastatic Breast Cancer
NCT01483300Phase 2Unknown
- Sponsor
- Harbin Medical University
- Start
- Nov 2011
- Primary completion
- Aug 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lobaplatin in breast cancer, sponsored by Harbin Medical University. Status: unknown.
02
Drugs
lobaplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01483300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01483300.